A Study on Ventilator-associated Pneumonia as a Risk for Nosocomial Infection in Mechanically Ventilated Neonates In NICU of Assiut University Children Hospital (Nicu Eta)

NCT03310840 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 140

Last updated 2020-12-23

No results posted yet for this study

Summary

Abstract

Background: Neonatal ventilator associated pneumonia (VAP) is a major hospital-acquired infection in acute care settings, associated with high mortality and poor outcome. VAP is considered a preventable infection if the risk factors are managed effectively. The purpose of this study is to evaluate prevalence of ventilator associated pneumonia, its causative organisms, its risk factors and outcome at our NICU.

This study used CDC guidelines for infant's ≤1 year old to diagnose neonatal VAP, in period from April 2018 to March 2019.

Conditions

  • Neonatal SEPSIS
  • Nosocomially Acquired Neonatal Sepsis

Interventions

OTHER

others

others

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Eligibility

Min Age
3 Days
Max Age
2 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-04-01
Primary Completion
2019-03-30
Completion
2019-10-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03310840 on ClinicalTrials.gov